Cooperative Agreement 72061720FA00002
Award Date
8/12/20
Completion Date
8/11/23
Dollars Obligated
$7.3M
Federal Agency
US Mission in Uganda
Federal Grant Program
98.001
Assistance Type
Cooperative Agreement
Place of Performance
Uganda
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $335,559 to the University of North Carolina at Chapel Hill to conduct a pilot randomized controlled trial on the feasibility, acceptability, and preliminary effectiveness of a Focal Mass Drug Administration (FMDA) program for household members of pregnant women to protect against malaria in pregnancy (MIP). The key...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $702,204 Cooperative Agreement under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the London School of Hygiene and Tropical Medicine (LSHTM) to conduct research on complex malaria in India. The key products and services to be delivered through this 5-year project include: Monitoring the changing epidemiology of malaria in Odisha, India through a 4-year community-based cohort study to...
The National Institute of Environmental Health Sciences (NIEHS) awarded a $272,910 Project Grant (CFDA 93.113 Environmental Health) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to optimize and evaluate the use of portable air cleaners (PACs) to reduce particulate matter (PM) exposure in low and middle-income households in Uganda. The project aims to: 1) identify environmental factors that maximize PM reduction with PAC use, 2) design and test an...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a longitudinal cohort study to examine the impact of early childhood malaria prevention interventions on malaria risk in school-age children in Ghana. The study, titled "IMPACT OF EARLY CHILDHOOD MALARIA PREVENTION ON MALARIA RISK AT SCHOOL ENTRY (ERASE)", will evaluate the epidemiological and...
This Project Grant award of $699,814 from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 - Allergy and Infectious Diseases Research, aims to study molecular mechanisms of Plasmodium parasite invasion in Anopheles mosquito midguts to identify novel targets for transmission-blocking malaria vaccines. The key products and services to be delivered under this award include: Functional characterization of identified mosquito and parasite proteins that mediate...
This $15,954,880 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) supports the Ministry of Health Central Public Health Laboratories (CPHL) in Uganda to strengthen the country's national health laboratory services and partnerships. The key objectives are to improve the quality of HIV-related testing and other diagnostics through enhanced laboratory coordination and management under the...
This Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas program (CFDA 98.001) provides $400,000.00 in funding to the University of Sciences, Techniques and Technologies of Bamako (Usttb) in Mali. The purpose of this award is to conduct entomological surveillance, insecticide-treated bed net durability monitoring, and routine monitoring of antimalarial drug efficacy and detection of resistance activities. The...
This Project Grant award of $743,488.00 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under CFDA Program 93.865 Child Health and Human Development Extramural Research, aims to examine the mechanisms and optimization of malaria chemoprevention strategies to improve birth outcomes in Africa. The research objectives are to: 1) characterize the mechanisms mediating the effects of sulfadoxine-pyrimethamine (SP) and dihydroartemisinin-piperaquine...
This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...
The federal Project Grant award of $101,290 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to strengthen grants administration capacity at the Makerere University College of Health Sciences in Uganda. The key products and services to be delivered under this award include: Providing advanced training and mentorship to senior research administrators at Makerere University on best practices for pre- and post-award...